Twin Cities med-tech company NxThera to be sold to Boston Scientific in $400M deal By: Minneapolis / St. Paul Business Journal via Business Journals March 21, 2018 at 12:23 PM EDT NxThera also will spin out a yet-to-be-named startup that will target the prostate cancer market. Read More >>